Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2886-2891

  Shah, Vallabh O ^a   Scavini, Marina ^c   Nikolic, Jovanka ^b   Sun, Yijuan ^a   Vai, Silvia ^c   Griffith, Jeffrey K ^a   Dorin, Richard I ^a   Stidley, Christine ^a   Yacoub, Mona ^a   Vander Jagt, David L ^a   Eaton, R Philip ^a   Zager, Philip G ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b Dialysis Clinic Inc   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; MICROSATELLITE DNA;

ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; GENETIC REGULATION; HEREDITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ALDEHYDE REDUCTASE; ALLELES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GENE EXPRESSION; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; RISK FACTORS;

EID: 15144342080     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2886     Document Type: Article

References (37)

1. Krolewski AS, Warram JH, Rand LI, Kahn CR. 1987 Epidemiologic approach to the etiology of the type 1 diabetes mellitus and its complications [Review]. N Engl J Med. 317:1390-1398.
2. Seaquist ER, Goetz FC, Rich S, Barbosa J. 1989 Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 320:1161-1165.
3. Krolewski AS, Doria A, Magre J, Warram JH, Housman D. 1997 Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus. J Am Soc Nephrol 3:S9-S17.
4. Teutsch S, Newman J, Eggers P. 1989 The problem of diabetic renal failure in the United States: an overview. Am J Kidney Dis. 13:11-13.
5. Cruz IA, Hosten AO. 1991 End stage renal disease in minorities. JAMA. 83:309-312.
6. Robinson Jr WG, Kador PF, Kinoshita JH. 1985 Early retinal microangiopathy: prevention with aldose reductase inhibitors. Diabetic Med. 2:196-199.
7. Imperatore G, Hanson RL, Pettitt DJ, et al. 1998 Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes mellitus. Diabetes. 47:821-830.
8. Kinoshita JH. 1965 Cataracts in galactosemia. Invest Ophthalmol. 4:786.
9. Robinson Jr WG, Kador PF, Kinoshita JH. 1983 Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science. 221:1177.
10. Kinoshita JH, Fukushi S, Kador P, Merola LO. 1979 Aldose reductase in diabetic complications of the eye. Metabolism. 28:462.
11. Ludvigson MA, Sorenson RL. 1980 Immunohistochemical localization of aldose reductase. Diabetes. 29:450.
12. Dorin RI, Shah VO, Kaplan D, Vela S, Zager PG. 1995 Regulation of aldose reductase gene expression in renal cortex and medulla of rats. Diabetologia. 38:46-54.
13. Zager PG, Dorin RI, Shah VO, Kaplan DL, Mann PL, Frey HJ, Deller T. 1993 Aldose reductase expression and prostaglandin E2 production are coordinately regulated in cultured rat mesangial cells. Metabolism. 42:269-276.
14. Kikkawa R, Umemura K, Haneda M, Arimura T, Ebata K, Shigeta Y. 1987 Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes. 36:240.
15. Grimshaw CE, Mathur EJ. 1989 Immunoquantitation of aldose reductase in human tissues. Anal Biochem. 176:66.
16. Bank N, Coco M, Aynedijian HS. 1989 Galactose feeding causes glomerular hyperfusion: prevention by aldose reductase inhibitors. Am J Physiol. 256:F994.
17. Bank N, Mower P, Aynedjian HS, et al. 1989 Sorbinil prevents glomerular hyperfusion in diabetic rats. Am J Physiol. 256:F1000.
18. Goldfarb S, Simmons DA, Kern EFO. 1986 Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition. Trans Assoc Am Physicians. 199:6.
19. Cunningham JJ, Mearkle PL, Brown RG. 1994 Vitamin C. An aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus. J Am Coll Nutr. 13:344-350.
20. Pedersen M, Christiansen JS, Mogensen CE. 1991 Reduction of glomerular hyperfiltration in normoalbuminic IDDM patients by six months of aldose reductase inhibition. Diabetes. 40:527-531.
21. Passariello N, Depe J, Marazzo G, et al. 1993 Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy. Diabetes Care. 16:789-795.
22. Yamakoto T, Nishimura C, Yamashita K, et al. 1995 Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia. 38:255-261.
23. Lee A, Chung SK, Chung SS. 1995 Demonstrate that polyol accumulations is responsible for diabetic cataract by the use of transgenic mice expressing aldose reductase gene. Proc Natl Acad Sci USA. 92:2780-8274.
24. Dent MT, Tebbs SE, Gonzalez AM, Ward JD, Wilson RM. 1991 Neutrophil aldose reductase activity and its association with established diabetic microvascular complications. Diabetic Med. 8:439-442.
25. Hamada Y, Kitoh R, Raskin P. 1991 Increased activity of erythrocyte aldose reductase in insulin-dependent diabetes with severe diabetic complications. Diabetes. 40(Suppl 1):9A.
26. Nishimura C, Saito T, Ito T, Omori Y, Tanimoto T. 1994 High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia. 37:328-330.
27. Ratliff DM, Vander Jagt DJ, Eaton RP, Vander Jagt DL. 1996 Increased levels of aldose reductase and glyoxalase I in mononuclear cells from IDDM. J Clin Endocrinol Metab. 41:1218-1250.
28. Shah VO, Dorin RI, Sun Y, Braun M, Zager PG. 1997 Aldose reductase gene expression is increased in diabetic nephropathy. J Clin Endocrinol Metab. 87:2294-2298.
29. Ko B, Lam K, Wat N, Chung S. 1995 An (A-C)n dinucleotide repeat polymorphic marker at the 5′ and of the aldose reductase gene is associated with early onset diabetic retinopathy in diabetic patients. Diabetes. 44:727.
30. Hessom AE, Hibberd ML, Miliward A, Demaine AG. 1997 Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type 1 diabetes. Diabetes. 46:287-291.
31. Heding LG. 1975 Radioimmunological determination of human C-peptide in serum. Diabetologia. 11:541-548.
32. Heding LG. 1977 Specific and direct radioimmunoassay for human proinsulin in serum. Diabetologia. 13:467-477.
33. Anonymous. 1982 Laboratory specimens. In: Diabetes control and complications trial: trial coordinator's handbook, chapt 8. 8.4.2.
34. World Health Organization. 1985 WHO multinational study of vascular disease in diabetes. Diabetologia. 28:615-640.
35. Ohtaka M, Tawata M, Hosaka Y, Onaya T. 1992 Glucose modulation of aldose reductase mRNA expression and its activity in cultured calf pulmonary artery endothelial cells. Diabetologia. 35:730-734.
36. Ruepp B, Bohren KM, Gabbay KH. 1996 Characterization of the osmotic response element of the human aldose reductase gene promotor. Proc Natl Acad Sci USA. 93:8624-8629.
37. Moczulski D, Rogus JJ, Warram JH, Krolewski AS. 1997 Exclusion of aldose reductase (AR) gene as a major locus for diabetic nephropathy (DN) in IDDM: results of family-based studies [Abstract 659]. Diabetes. 46:171A.